Skip to content

CNAP survey

Survey on the Effect of CNAP (Continuous Negative Abdominal Pressure) in Maintaining Oxygenation after Liberation from Mechanical Ventilation

Status
Recruiting
Phases
Phase 3
Study type
Interventional
Source
JPRN
Registry ID
JPRN-jRCT1042250098
Enrollment
104
Registered
2025-09-18
Start date
2025-11-01
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Postoperative respiratory failure after cardiac surgery requiring cardiopulmonary bypass

Interventions

In addition to standard therapy, CNAP will be applied using the extracorporeal positive and negative pressure ventilator TCV-100K (IMI Co., Ltd., Saitama, Japan).

Sponsors

Yamaguchi Takumi
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: Patients who underwent cardiac surgery with cardiopulmonary bypass. Patients who were weaned from invasive mechanical ventilation within one week after surgery. At the time of invasive mechanical ventilation weaning, patients with a PaO2/FiO2 ratio > 200 and PEEP 20%. Written informed consent for participation in this study has been obtained from the patient or a legally authorized representative.

Exclusion criteria

Exclusion criteria: Patients younger than 18 years of age at the time of consent. Patients who have undergone surgical procedures involving abdominal incision and who have surgical wounds in the abdominal region. Patients with skin lesions at the intended CNAP application site that make appropriate application difficult. Patients who are pregnant or may be pregnant. Patients in whom, due to physical characteristics or device limitations, the target continuous negative pressure cannot be stably maintained after CNAP application. Patients for whom, at the time of liberation from invasive positive pressure ventilation (IPPV), noninvasive positive pressure ventilation (NPPV) was deemed medically necessary.

Design outcomes

Primary

MeasureTime frame
Change in the PaO2/FiO2 ratio from the time of extubation to 24 hours after extubation

Secondary

MeasureTime frame
PaO2/FiO2 ratio and respiratory rate at 0, 6, 12, 18, and 24 hours after extubation Rate of reintroduction of noninvasive positive pressure ventilation (NPPV) or invasive positive pressure ventilation (IPPV) by reintubation, and time to event Incidence of skin complications at the CNAP application site

Contacts

Public ContactTakumi Yamaguchi

Department of Anesthesia and Intensive Care, Japnanese Red Cross Aichi Medical Center Nagoya Daini Hospital

tynmu148945@gmail.com+81-8057185853

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026